Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human Tiki2/TRABD2B Antibody, R&D Systems™
GREENER_CHOICE

Sheep Polyclonal Antibody

Supplier:  R&D Systems AF1600SP

 View more versions of this product

Catalog No. AF1600SP


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

Tiki2/TRABD2B Polyclonal specifically detects Tiki2/TRABD2B in Human samples. It is validated for Western Blot, Flow Cytometry.
Specifications

Specifications

Tiki2/TRABD2B
Polyclonal
Western Blot 0.5 ug/mL, Flow Cytometry 0.25 ug/mL
A6NFA1
Sheep
Antigen Affinity-purified
RUO
388630
Reconstitute at 0.2 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Western Blot, Flow Cytometry
Unconjugated
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
HKAT, TIKI2, TRABD2B, TRABD2B TraB domain containing 2B
Human embryonic kidney cell line HEK293-derived transfected with human Tiki2/TRABD2B Accession # A6NFA1
25 μg
Primary
Detects human Tiki2/TRABD2B in direct ELISAs and Western blots.
Human
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.